1. Home
  2. SLGL vs CSTE Comparison

SLGL vs CSTE Comparison

Compare SLGL & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • CSTE
  • Stock Information
  • Founded
  • SLGL 1997
  • CSTE 1987
  • Country
  • SLGL Israel
  • CSTE Israel
  • Employees
  • SLGL N/A
  • CSTE N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • CSTE Building Materials
  • Sector
  • SLGL Health Care
  • CSTE Industrials
  • Exchange
  • SLGL Nasdaq
  • CSTE Nasdaq
  • Market Cap
  • SLGL 69.1M
  • CSTE 61.9M
  • IPO Year
  • SLGL 2018
  • CSTE 2012
  • Fundamental
  • Price
  • SLGL $33.66
  • CSTE $1.00
  • Analyst Decision
  • SLGL Strong Buy
  • CSTE
  • Analyst Count
  • SLGL 1
  • CSTE 0
  • Target Price
  • SLGL $50.00
  • CSTE N/A
  • AVG Volume (30 Days)
  • SLGL 11.7K
  • CSTE 123.7K
  • Earning Date
  • SLGL 11-07-2025
  • CSTE 11-12-2025
  • Dividend Yield
  • SLGL N/A
  • CSTE N/A
  • EPS Growth
  • SLGL N/A
  • CSTE N/A
  • EPS
  • SLGL N/A
  • CSTE N/A
  • Revenue
  • SLGL $23,931,000.00
  • CSTE $406,178,000.00
  • Revenue This Year
  • SLGL N/A
  • CSTE N/A
  • Revenue Next Year
  • SLGL N/A
  • CSTE $5.61
  • P/E Ratio
  • SLGL N/A
  • CSTE N/A
  • Revenue Growth
  • SLGL 264.86
  • CSTE N/A
  • 52 Week Low
  • SLGL $4.01
  • CSTE $1.05
  • 52 Week High
  • SLGL $52.26
  • CSTE $5.04
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 45.02
  • CSTE 23.41
  • Support Level
  • SLGL $30.85
  • CSTE $1.20
  • Resistance Level
  • SLGL $39.00
  • CSTE $1.48
  • Average True Range (ATR)
  • SLGL 2.87
  • CSTE 0.11
  • MACD
  • SLGL -1.25
  • CSTE -0.02
  • Stochastic Oscillator
  • SLGL 22.17
  • CSTE 4.00

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

Share on Social Networks: